CAR-T, cancer cell

In an interview with Arthur Stril, chief business officer and interim CFO at Cellectis, we explore how gene editing and ...
Scientists have supercharged CAR-T therapy, making it more powerful against elusive cancer cells that usually escape ...
This cancer-patient dad of three young kids is grateful for a "sci-fi" blood treatment advanced by Vanderbilt and oncologist Dr. Olalekan Oluwole.
Although chimeric antigen receptor T-cell therapy has raised hopes for long-term remission in autoimmune disease, it has ...
The following is a summary of “Late Adverse Events After Chimeric Antigen Receptor T-Cell Therapy for Patients With ...
Protheragen is an advanced CAR-T cell therapy service provider. With its extensive experience in cell therapy development and ...